149Rca Cells
| CAT.NO | UNIT | PRICE |
|---|---|---|
| T8331 | 1x106 cells / 1.0 ml | $0.00 |
| Description | 149RCa cells were derived from a male human with penile squamous cell carcinoma. The cell line is tuminorgic in mice and has a very high proliferation rate and metastasis potential. The 149RCa cells are sensitive to cisplatin however they are resistant to anti-EGFR therapy and unresponsive to androgen. The 149RCa cell line may be used for further investigation of penile squamous cell carcinoma and development of relevent therapeutic treatment. |
|---|---|
| SKU | T8331 |
| Species | Human (H. sapiens) |
| Donor Gender | Male |
| Donor Disease | Penile squamous cell carcinoma |
| Growth Properties | Adherent |
| Cell Morphology | Epithelial-like |
| Seeding Density | 30,000 - 40,000 cells/cm2; Recommended split ratio is 1:3 or 1:8 |
| Applications | For Research Use Only |
| Unit quantity | 1x106 cells / 1.0 ml |
| Cell Type | Tumor Cells |
| Propagation Requirements | Use of PriCoat™ T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) is required for cell adhesion to the culture vessels. PriGrow III (TM003) + 10% FBS + 1% Penicillin/Streptomycin Solution (G255), 37.0°C, 5% CO₂ |
| Disclaimer |
1. For for-profit organizations and corporations, please contact [email protected] for pricing of this item.
2. Sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchasing individual/institution for each order. If you have any questions regarding this, please contact us at [email protected].
3. All test parameters provided in the CoA are conducted using abm's standardized culture system and procedures. The stated values may vary under the end-user's culture conditions. Please verify that the product is suitable for your studies by referencing published papers or ordering RNA (0.5 μg, Cat.# C207, $450.00) or cell lysate (100 μg, Cat.# C206, $600.00) to perform preliminary experiments, or alternatively use our Gene Expression Assay Service (Cat# C138). All sales are final.
4. We recommend live cell shipments for ease of cell transfer and this option can be requested at the time of ordering. Please note that the end-user will need to evaluate the feasibility of live cell shipment by taking into account the final destination's temperature variation and its geographical location. In addition, we thoroughly test our cell lines for freeze-thaw recovery. If frozen cells were received and not recovered in your lab under the exact, specified conditions (using recommended culture vessel, media, additional supplements, and atmospheric conditions), a live cell replacement is possible at a cost (plus shipping).
5. All of abm's cell biology products are for research use ONLY and NOT for therapeutic/diagnostic applications. abm is not liable for any repercussions arising from the use of its cell biology product(s) in therapeutic/diagnostic application(s). Please contact a technical service representative for more information.
6. abm makes no warranties or representations as to the accuracy of the information on this site. Citations from literature and provided for informational purposes only. abm does not warrant that such information has been shown to be accurate. 7. abm warrants that cell lines shall be viable upon initiation of culture for a period of thirty (30) days after shipment and that they shall meet the specifications on the applicable abm Material Product Information sheet, certificate of analysis, and/or catalog description. Such thirty (30) day period is referred to herein as the "Warranty Period." |
| Depositor | Sun Yat-sen University Cancer Center (Hui Han) |
4
- Chen, J., Yao, K., Li, Z., Deng, C., Wang, L., Yu, X., Liang, P., Xie, Q., Chen, P., Qin, Z., Ye, Y., Liu, Z., Zhou, F., Zhang, Z., & Han, H. (2016). Establishment and characterization of a penile cancer cell line, penl1, with a deleterious TP53 mutation as a paradigm of HPV-negative penile carcinogenesis. Oncotarget, 7(32), 51687–51698. https://doi.org/10.18632/oncotarget.10098
- Zhou, Q. H., Deng, C. Z., Li, Z. S., Chen, J. P., Yao, K., Huang, K. B., Liu, T. Y., Liu, Z. W., Qin, Z. K., Zhou, F. J., Huang, W., Han, H., & Liu, R. Y. (2018). Molecular characterization and integrative genomic analysis of a panel of newly established penile cancer cell lines. Cell death & disease, 9(6), 684. https://doi.org/10.1038/s41419-018-0736-1
- Hitora, T., Yamamoto, T., Akisue, T., Marui, T., Nakatani, T., Kawamoto, T., ... & Kurosaka, M. (2005). Establishment and characterization of a KIT‐positive and stem cell factor‐producing cell line, KTHOS, derived from human osteosarcoma. Pathology international, 55(2), 41-47.